These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26705257)

  • 1. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
    Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
    Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
    Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
    PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Peptidome Pattern of Breast Cancer Using Magnetic Beads-Based Plasma Fractionation and MALDI-TOF MS: A Case Control Study in Egypt.
    Zaki A; Ramadan RA; Moez P; Ghareeb H; Elkarmouty A
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):175-184. PubMed ID: 30678429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
    Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
    J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery.
    Boccardo F; Rubagotti A; Nuzzo PV; Argellati F; Savarino G; Romano P; Damonte G; Rocco M; Profumo A
    Int J Cancer; 2015 Nov; 137(10):2394-402. PubMed ID: 25994113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
    Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C
    J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein C1 (APOC1), A Candidate Diagnostic Serum Biomarker for Breast Cancer Identified by Serum Proteomics Study.
    Yan Y; Zhou Y; Wang K; Qiao Y; Zhao L; Chen M
    Crit Rev Eukaryot Gene Expr; 2022; 32(4):1-9. PubMed ID: 35695660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis.
    Fan NJ; Gao CF; Zhao G; Wang XL; Liu QY
    Diagn Pathol; 2012 Apr; 7():45. PubMed ID: 22521044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
    Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
    Shevchenko VE; Arnotskaya NE; Zaridze DG
    Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of serum proteomic mass spectrum analysis in breast cancer].
    Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases.
    Terracciano R; Preianò M; Palladino GP; Carpagnano GE; Barbaro MP; Pelaia G; Savino R; Maselli R
    Proteomics; 2011 Aug; 11(16):3402-14. PubMed ID: 21751363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
    Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F
    Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Zheng N; Pan C; Liu W
    J Int Med Res; 2011; 39(4):1184-92. PubMed ID: 21986120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers screening between preoperative and postoperative patients in pancreatic cancer.
    Li P; Yang J; Ma QY; Wu Z; Huang C; Li XQ; Wang Z
    Asian Pac J Cancer Prev; 2013; 14(7):4161-5. PubMed ID: 23991970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
    Fan NJ; Gao CF; Wang XL; Zhao G; Liu QY; Zhang YY; Cheng BG
    J Biomed Biotechnol; 2012; 2012():985020. PubMed ID: 23091368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC.
    Song Y; Xu X; Wang N; Zhang T; Hu C
    J Clin Lab Anal; 2022 Apr; 36(4):e24254. PubMed ID: 35212031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and identification of serum protein peak at 6648 m/z as a novel indicator in breast cancer based on mass spectrometry.
    Song D; Yue L; Zhan Y; Zhang J; Yan Z; Fan Y; Yang H; Zhang D; Liu Q; Xia Z; Qin P; Jia J; Yue M; Yu J; Zheng S; Yang F; Wang J
    Discov Med; 2017 May; 23(128):283-294. PubMed ID: 28715644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.